Predicting complications of pregnancy with first-trimester maternal serum free-βhCG, PAPP-A and inhibin-A
Predicting complications of pregnancy with first-trimester maternal serum free-βhCG, PAPP-A and inhibin-A
复制标题
DOI:
10.1002/pd.735
复制
发表时间:
2003-12-15
影响因子:
3
通讯作者:
Novak-Antolic, Z
中科院分区:
文献类型:
--
作者:
Tul, N;Pusenjak, S;Novak-Antolic, Z
Objective To find whether fbetahCG, PAPP-A and inhibin-A levels in maternal serum or fetal nuchal translucency (NT) thickness at the first-trimester screening for trisomy 21 (T21) might detect women at high risk for adverse pregnancy outcomes.Methods A retrospective analysis of 1136 women with singleton pregnancy between 10 and 14 weeks. Women with pregnancy complications were allotted to five subgroups: small for gestational age (SGA), large for gestational age (LGA), gestational diabetes (GDM), hypertensive disorders, preterm delivery; women with normal pregnancy represented the control group. NT, maternal serum fbetaCG, PAPP-A and inhibin-A were measured. Mann-Whitney test was used for the comparison of fbetahCG, PAPP-A, inhibin-A and NT between a subgroup of a certain pregnancy complication and the control group. Multivariate logistic regression models were built to explore the relationship among different variables and the occurrence of pregnancy complications.Results PAPP-A values were significantly lower in women who delivered SGA babies (n = 51, 0.76 MoM; p = 0.002) and significantly higher in women who delivered LGA babies (n = 120, 1.12 MoM; p = 0.036). In women with GDM (n = 27), fbetahCG, PAPP-A and inhibin-A were insignificantly lower than in controls, whereas in women with hypertensive disorders (n = 56) no significant differences between the groups were found. In women with a preterm delivery (